Nicoletta Loggia Acquires Stock Option for Candel Therapeutics Inc.

Nicoletta Loggia, a director at Candel Therapeutics, Inc., acquired a stock option on June 23, 2026, for 32,000 shares of Common Stock. The option, with an exercise price of $9.08, is subject to time-based vesting. The shares will vest and become exercisable on the earlier of June 23, 2027, or the next Annual Meeting of Stockholders, provided Loggia continues to serve as a director. The option expires on June 23, 2036. This transaction is reported on Form 4.